Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1987-12-14
1991-01-15
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424 858, 514 2, 514 3, 514 11, 514 12, A61K 3766, A61K 3900, A61K 3700, A61K 3726
Patent
active
049852426
ABSTRACT:
An intranasally applicable powdery pharmaceutical composition comprising a polypeptide having a physiological activity, a quaternary ammonium compound, and a lower alkyl ether of cellulose. This powdery pharmaceutical composition has an excellent preservability and chemical stability of the polypeptides and, when the powdery composition is administered to the nasal cavity in the form of a spray, the polypeptides are effectively absorbed through the nasal mucosa.
REFERENCES:
patent: 4613500 (1986-09-01), Suzuki et al.
S. Hirai et al, Diabetes vol. 27, p. 296, (1978).
Araki Daisuke
Sekine Kunio
Suzuki Yoshiki
Teljin Limited
Waddell Frederick E.
LandOfFree
Intranasally applicable powdery pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intranasally applicable powdery pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intranasally applicable powdery pharmaceutical composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-54322